In a new feature for the @nypost, Allie Yang explores what’s next for cancer vaccines and the patients already seeing the potential firsthand. @kristendahlgren, Chief External Affairs Officer at Parker, shares why this could be a defining moment for cancer patients: “I think we’re about to change things profoundly for cancer patients.” The article also features Parker Institute researchers who are working to accelerate the science and bring the promise of cancer immunotherapy closer to more patients. ​​nypost.com/2026/09/29/health…

“This is a completely new frontier.” In @nytimes, @DrKarenKnudsen, Parker Institute CEO, tells @ginakolata about the promise of cancer vaccines and a new NIH initiative to accelerate their development. Parker researcher Dr. Catherine Wu of @DanaFarber and Dr. Vinod Balachandran of @MSKCancerCenter are among the scientists advancing personalized cancer vaccines through promising early research. With greater collaboration and coordinated efforts, the field has an opportunity to accelerate progress and bring new treatment options to patients facing some of the hardest-to-treat cancers. Read more: nytimes.com/2026/10/09/scien…

Parker Institute’s @kristendahlgren and @DrKarenKnudsen joined @NBCNews’ @VickyNguyenTV and @SamBrockNBC to talk about the evolution of therapeutic cancer vaccines, Kristen’s own experience with breast cancer, and the work underway through the Parker Institute to accelerate research. As Kristen shared, this is no longer just a science problem. Collaboration, coordination, and funding will be critical to turning promising research into treatments that can make a difference for people with cancer. Watch the full conversation: